CTI BioPharma
Manufacturing · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3101 Western Ave Ste 800, Seattle, Washi...Phone Number
(206) 282-7100Website
www.ctibiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About CTI BioPharma
Founded in 1991, CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a commercial presence in Europe. CTI BioPharma is headquartered in Seattle, Washington.Explore more
CTI BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CTI BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CTI BioPharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CTI BioPharma
Funding: Get notified immidiatlly once CTI BioPharma has new funding data
Product Launch: Get notified when CTI BioPharma launches new products
CTI BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if CTI BioPharma had a recent Job posting/layoffs
Earning: See what the market has to say on CTI BioPharma recently announced quarterly report
Check if CTI BioPharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined CTI BioPharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to CTI BioPharma
Compare insights from companies similar to CTI BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$17.1M
11-50
Private
$44M
1998
MG
Mark GiovanettiSenior Director Technical Accounting and Secretary Reporting
Company Profile Activity
Activity Insights
CTI BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CTI BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CTI BioPharma.
CTI BioPharma financials insights
Gather financial insights about CTI BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$30M
2021
Other Financing Round
$135M
CTI BioPharma Tech Stack
A closer look at the technologies used by CTI BioPharma
See more technologies
Most Recent Scoops
Person-Based
Facilities Relocation / Expansion
CTI BioPharma is planning to move offices in January 2025. The move will impact approximately 36 employees at the existing office located at 3101 Western Ave, Suite # 800, Seattle, WA.
Facilities Relocation/Expansion
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Open Position
CTI BioPharma News & Media
Top Growth Stocks for July 2023
Top growth stocks this month include Applied Digital, TG Therapeutics, and Immunovant, all of whose share prices have all gained more than 400% in the past year.Top Stocks for July 2023
Vital Energy, CTI BioPharma, and Applied Digital are top U.S. stocks in the Russell 3000 in July 2023 for value, growth, and momentum, respectively.Sobi completes acquisition of CTI BioPharma Corp.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the completion of the11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical Stocks Under $10. The medical industry is one of the most capitally intensive and competitive sectors in the […]
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CTI BioPharma
Sign Up For FreeTo access detailed company insights
Founded in 1991, CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a commercial presence in Europe. CTI BioPharma is headquartered in Se... Read More
